Huang ZH - Search Results

1

Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma.

Huang ZH, Hu Y, Hua D, Wu YY, Song MX, Cheng ZH. Huang ZH, et al. Exp Mol Pathol. 2011 Dec;91(3):702-7. doi: 10.1016/j.yexmp.2011.08.004. Epub 2011 Aug 22. Exp Mol Pathol. 2011. PMID: 21884695

2

Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.

Huang ZH, Li LH, Hua D. Huang ZH, et al. Cancer Lett. 2006 Nov 8;243(1):64-70. doi: 10.1016/j.canlet.2005.11.027. Epub 2006 Jan 18. Cancer Lett. 2006. PMID: 16412565

3

Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.

Huang ZH, Li LH, Yang F, Wang JF. Huang ZH, et al. World J Gastroenterol. 2007 Feb 14;13(6):950-4. doi: 10.3748/wjg.v13.i6.950. World J Gastroenterol. 2007. PMID: 17352030 Free PMC article.

4

Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.

Huang Z, Li L, Wang J. Huang Z, et al. Dig Dis Sci. 2007 Sep;52(9):2287-91. doi: 10.1007/s10620-007-9755-y. Epub 2007 Apr 5. Dig Dis Sci. 2007. PMID: 17410438

5

Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.

Hua D, Huang ZH, Mao Y, Deng JZ. Hua D, et al. Among authors: huang zh. World J Gastroenterol. 2007 Oct 7;13(37):5030-4. doi: 10.3748/wjg.v13.i37.5030. World J Gastroenterol. 2007. PMID: 17854149 Free PMC article. Clinical Trial.

6

Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy.

Huang ZH, Hua D, Li LH, Zhu JD. Huang ZH, et al. J Cancer Res Clin Oncol. 2008 Oct;134(10):1129-34. doi: 10.1007/s00432-008-0380-8. Epub 2008 Mar 21. J Cancer Res Clin Oncol. 2008. PMID: 18357466

7

The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.

Huang ZH, Hua D, Li LH. Huang ZH, et al. Cancer Chemother Pharmacol. 2009 Apr;63(5):911-8. doi: 10.1007/s00280-008-0815-6. Epub 2008 Aug 15. Cancer Chemother Pharmacol. 2009. PMID: 18704422

8

ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer.

Huang ZH, Hua D, Du X, Li LH, Mao Y, Liu ZH, Song MX, Zhou XK. Huang ZH, et al. World J Gastroenterol. 2008 Nov 7;14(41):6401-7. doi: 10.3748/wjg.14.6401. World J Gastroenterol. 2008. PMID: 19009659 Free PMC article.

9

Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.

Huang ZH, Hua D, Du X. Huang ZH, et al. Cancer Chemother Pharmacol. 2009 Oct;64(5):1001-7. doi: 10.1007/s00280-009-0956-2. Epub 2009 Feb 27. Cancer Chemother Pharmacol. 2009. PMID: 19247656

10

TNRC9/LOC643714 polymorphisms are not associated with breast cancer risk in Chinese women.

Li L, Zhou X, Huang Z, Liu Z, Song M, Guo Z. Li L, et al. Eur J Cancer Prev. 2009 Aug;18(4):285-90. doi: 10.1097/CEJ.0b013e32832bf421. Eur J Cancer Prev. 2009. PMID: 19398914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

820 results

Search Page

Filters